ArticlePediatric cardiology2026
Treatment Outcomes and Temporal Changes in Pleural Fluid Characteristics in Persistent Postoperative Chylothorax Following Congenital Heart Surgery.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative chylothorax remains a significant complication after congenital heart surgery; however, little is known about temporal changes in pleural fluid characteristics during prolonged disease. We retrospectively reviewed 82 children with postoperative chylothorax treated between 2007 and 2023 to evaluate the outcomes of a stepwise treatment strategy, identify factors associated with refractory disease, and investigate serial pleural fluid findings. Patients were managed with dietary modification, total parenteral nutrition, octreotide, and additional intervention when necessary. Conservative management successfully resolved chylothorax in 70 patients (85.4%), whereas 12 (14.6%) required additional intervention. Multivariable Firth penalized logistic regression identified greater pleural drainage volume (adjusted OR, 1.83 per 10 mL/kg/day increase; P = 0.025) and superior vena cava stenosis or obstruction (adjusted OR, 75.94; P < 0.001) as independent predictors of additional intervention or death. Serial pleural fluid analyses demonstrated progressive declines in white blood cell counts despite persistent mononuclear cell predominance, while triglyceride concentrations remained below the conventional diagnostic threshold throughout prolonged chylothorax. These findings suggest that conventional pleural fluid criteria alone may underestimate persistent postoperative chylothorax during long-term follow-up. Assessment of refractory chylothorax should therefore integrate the clinical course, hemodynamic findings, and imaging studies in addition to pleural fluid analysis.
Indexed as
Identifiers
42640470What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.